Christopher C Nessel Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

3/2016	Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.
3/2014	Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher C Nessel Research Topics

Disease

51	Stroke (Strokes) 10/2021 - 09/2011
46	Atrial Fibrillation 10/2021 - 09/2011
41	Embolism (Embolus) 10/2021 - 09/2011
34	Hemorrhage 01/2019 - 07/2004
10	Myocardial Infarction 01/2019 - 07/2004
8	Heart Failure 01/2019 - 07/2013
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 09/2011
4	Acute Coronary Syndrome 12/2006 - 07/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2016
3	Transient Ischemic Attack 05/2014 - 01/2013
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 10/2018
2	Carotid Artery Diseases 01/2018 - 01/2018
2	Ischemic Stroke 11/2017 - 09/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2016 - 03/2014
2	Mitral Valve Stenosis (Mitral Stenosis) 01/2016 - 12/2014
2	Anemia 12/2015 - 03/2014
2	Hemorrhagic Stroke 07/2014 - 07/2013
1	Neoplasms (Cancer) 01/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Overweight 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 03/2016
1	Cerebral Hemorrhage 10/2015
1	Sudden Death 06/2015
1	Aortic Valve Disease 12/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Thrombosis (Thrombus) 07/2013

Drug/Important Bio-Agent (IBA)

50	RivaroxabanIBA 10/2021 - 09/2011
43	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 09/2011
32	Vitamin K FDA Link 10/2021 - 01/2013
31	Factor Xa (Coagulation Factor Xa)IBA 10/2021 - 01/2013
4	AnticoagulantsIBA 01/2018 - 07/2013
4	CreatinineIBA 03/2016 - 01/2013
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 01/2014
4	Heparin (Liquaemin)FDA LinkGeneric 12/2006 - 07/2004
4	Enoxaparin (Lovenox)FDA LinkGeneric 12/2006 - 07/2004
3	Factor Xa InhibitorsIBA 07/2014 - 10/2011
2	Thrombin FDA Link 10/2018 - 07/2013
2	Glycoproteins (Glycoprotein)IBA 12/2006 - 08/2004
1	Insulin (Novolin)FDA Link 06/2021
1	A-factor (Streptomyces)IBA 10/2018
1	Natriuretic PeptidesIBA 10/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2017
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2017
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2017
1	Cytochrome P-450 CYP3AIBA 01/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016
1	Digoxin (Digitek)FDA LinkGeneric 06/2015
1	Anti-Arrhythmia AgentsIBA 06/2014
1	Amiodarone (Amiodarona)FDA LinkGeneric 06/2014
1	Serum AlbuminIBA 05/2014
1	FibrinIBA 07/2013
1	Prothrombin (Factor II)IBA 07/2013
1	Fibrinogen (Factor I)FDA Link 07/2013
1	Streptokinase FDA Link 07/2004
1	AntithrombinsIBA 07/2004

Therapy/Procedure

11	Therapeutics 01/2019 - 07/2004
2	Polypharmacy 07/2016 - 01/2016
2	Percutaneous Coronary Intervention 01/2016 - 12/2006
2	Prostheses and Implants (Prosthesis) 01/2016 - 12/2014
1	Drug Therapy (Chemotherapy) 06/2021
1	Aftercare (After-Treatment) 10/2018
1	Endarterectomy (Thromboendarterectomy) 01/2018
1	Thrombolytic Therapy 11/2017
1	Electric Countershock (Cardioversion) 05/2013
1	Catheter Ablation 05/2013
1	Blood Transfusion (Blood Transfusions) 07/2004